Shi-Yuan Cheng

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Venues

ACS medicinal chemistry letters

Neuro-oncology

Cancers

Biomedicines

Northwestern University Feinberg School of Medicine

Ohio State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Northwestern University Feinberg School of Medicine Jul 01 2012

United States

Professor :: Neurology

University of Pittsburgh Apr 01 1999 - Jun 30 2012

United States

Assistant then Associate professor :: Cancer Institute & Pathology

Education History

Ohio State University Sep 25 1985 - Jun 25 1992

United States

PHD :: Ohio State Biochemistry Program

Wuhan University Mar 20 1978 - Jan 30 1982

China

BSC :: Biology

Publications

Dalton R Kim, Meghan J Orr, Xiaozhou Yu, Hasan H Munshi, Austin Wang, Claire Trudeau, Ada J Kwong, Shi-Yuan Cheng, Karl A Scheidt
Synthesis and Structural Optimization of ATG4B Inhibitors for the Attenuation of Autophagy in Glioblastoma. ACS medicinal chemistry letters 15 (2) (2024)
Dalton R Kim, Meghan J Orr, Xiaozhou Yu, Hasan H Munshi, Austin Wang, Claire Trudeau, Ada J Kwong, Shi-Yuan Cheng, Karl A Scheidt
Synthesis and Structural Optimization of ATG4B Inhibitors for the Attenuation of Autophagy in Glioblastoma. ACS medicinal chemistry letters 15 (2) (2024)
Dalton R Kim, Meghan J Orr, Xiaozhou Yu, Hasan H Munshi, Austin Wang, Claire Trudeau, Ada J Kwong, Shi-Yuan Cheng, Karl A Scheidt
Synthesis and Structural Optimization of ATG4B Inhibitors for the Attenuation of Autophagy in Glioblastoma. ACS medicinal chemistry letters 15 (2) (2024)
Michael A Sun, Rui Yang, Heng Liu, Wenzhe Wang, Xiao Song, Bo Hu, Nathan Reynolds, Kristen Roso, Lee H Chen, Paula K Greer, Stephen T Keir, Roger E McLendon, Shi-Yuan Cheng, Darell D Bigner, David M Ashley, Christopher J Pirozzi, Yiping He
Repurposing Clemastine to Target Glioblastoma Cell Stemness. Cancers 15 (18) (2023)
Deanna Marie Tiek, Beril Erdogdu, Roham Razaghi, Lu Jin, Norah Sadowski, Carla Alamillo-Ferrer, J Robert Hogg, Bassem R Haddad, David Harold Drewry, Carrow I Wells, Julie E Pickett, Xiao Song, Anshika Goenka, Bo Hu, Samuel A Goldlust, William J Zuercher, Mihaela Pertea, Winston Timp, Shi-Yuan Cheng, Rebecca B Riggins
Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomas. Science advances 8 (25) (2022)
Anshika Goenka, Deanna Marie Tiek, Xiao Song, Rebeca Piatniczka Iglesia, Minghui Lu, Bo Hu, Shi-Yuan Cheng
The Role of Non-Coding RNAs in Glioma. Biomedicines 10 (8) (2022)
Anshika Goenka, Shi-Yuan Cheng
Targeting neddylation in cancer. Neuro-oncology 24 (11) (2022)
Deanna Marie Tiek, Shi-Yuan Cheng
New life for an old therapy: ELTD1 as a downstream target of angiogenesis. Neuro-oncology 24 (3) (2022)
Matthew McCord, Elizabeth Bartom, Kirsten Burdett, Aneta Baran, Frank D Eckerdt, Irina V Balyasnikova, Kathleen McCortney, Thomas K Sears, Shi-Yuan Cheng, Jann N Sarkaria, Roger Stupp, Amy B Heimberger, Atique U Ahmed, Charles David James, Craig M Horbinski
Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts. Cancers 14 (22) (2022)
Anshika Goenka, Deanna Marie Tiek, Xiao Song, Tianzhi Huang, Bo Hu, Shi-Yuan Cheng
The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma. Cells 10 (3) (2021)
Xinya Gao, Xin Xia, Fanying Li, Maolei Zhang, Huangkai Zhou, Xujia Wu, Jian Zhong, Zheng Zhao, Kun Zhao, Dawei Liu, Feizhe Xiao, Qiang Xu, Tao Jiang, Bo Li, Shi-Yuan Cheng, Nu Zhang
Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling. Nature cell biology 23 (3) (2021)
Jian-Hua Luo, Silvia Liu, Junyan Tao, Bao-Guo Ren, Katherine Luo, Zhang-Hui Chen, Michael Nalesnik, Kathleen Cieply, Tianzhou Ma, Shi-Yuan Cheng, Qi Chen, George K Michalopoulos, Joel B Nelson, Rohit Bhargava, Jun Zhang, Deqin Ma, David Jarrard, Arjun Pennathur, James D Luketich, Donald B DeFranco, Satdarshan Paul Monga, George Tseng, Yan-Ping Yu
Pten-NOLC1 fusion promotes cancers involving MET and EGFR signalings. Oncogene 40 (6) (2020)
Youzhou Sang, Yanxin Li, Yingwen Zhang, Angel A Alvarez, Bo Yu, Weiwei Zhang, Bo Hu, Shi-Yuan Cheng, Haizhong Feng
CDK5-dependent phosphorylation and nuclear translocation of TRIM59 promotes macroH2A1 ubiquitination and tumorigenicity. Nature communications 10 (1) (2019)
Tianzhi Huang, Xuechao Wan, Angel A Alvarez, C David James, Xiao Song, Yongyong Yang, Namratha Sastry, Ichiro Nakano, Erik P Sulman, Bo Hu, Shi-Yuan Cheng
MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy. Autophagy 15 (6) (2019)
Xiao Song, Xuechao Wan, Tianzhi Huang, Chang Zeng, Namratha Sastry, Bingli Wu, C David James, Craig Horbinski, Ichiro Nakano, Wei Zhang, Bo Hu, Shi-Yuan Cheng
SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes. Cancer research 79 (20) (2019)
Rajendra P Pangeni, Zhou Zhang, Angel A Alvarez, Xuechao Wan, Namratha Sastry, Songjian Lu, Taiping Shi, Tianzhi Huang, Charles X Lei, C David James, John A Kessler, Cameron W Brennan, Ichiro Nakano, Xinghua Lu, Bo Hu, Wei Zhang, Shi-Yuan Cheng
Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma. Epigenetics 13 (4) (2018)

Shi-Yuan Cheng.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shi-Yuan Cheng